2Gao C, Zhao XX, Li WJ, et al. Clinical features, early treatment responses, and outcomes of pediatric acute lymphoblastic leukemia in China with or without specific fusion transcripts : a single institutional study of 1,004 patients. Am J I-tematol, 2012 , 87 ( 11 ) : 1022 - 1027.
3Rubnitz JE, Wichlan D, Devidas M, et al. Prospective analysis of TEL gene rearrangements in childhood acute lymphoblastic leukemia : a Children's Oncology Group study. J Clin Oncol,2008 ,26 (13): 2186 -2191.
4Forestier E, Heyman M, Andersen MK, et al. Outcome of ETV6/ RUNX1-positive childhood acute lymphoblastic leukaemia in the NO- PHO-ALL-1992 protocol: frequent late relapses but good overall sur- vival. Br J Haematol,2008 , 140 (6) :665 - 672.
5Bruggemann M, Schrauder A, Raft T, et al. Standardized MRD quantification in European ALL trials : proceedings of the Second In- ternational Symposium on MRD assessment in Kiel, Germany, 18 - 20 September 2008. Leukemia,2010 ,24 (3) :521 - 535.
6van der Velden VH, Cazzaniga G, Schrauder A, et al. Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data. Leukemia, 2007 ,21 (4) :604 -611.
7van der Velden VH, Panzer-Grumayer ER, Cazzaniga G, et al. Op- timization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center setting. Leukemia,2007 , 21 ( 4 ) :706 - 713.
8Nguyen K, Devidas M, Cheng SC, et al. Factors influencing surviv- al after relapse from acute lymphoblastic leukemia: a Children's On- cology Group study. Leukemia,2008 ,22(12) :2142 - 2150.
